Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지

Cytolytic Effects of an Adenoviral Vector Containing L-Plastin Promoter Regulated E1A in Hepatocellular Carcinoma Cells

  • Published : 2006.09.25
Download PDF
⟨ Previous Next ⟩

Abstract

We have previously reported that 2.4 kb of L-plastin promoter (LP) could regulate the expression of adenoviral vector (AV) exogenous genes in a tumor cell specific manner. In the present study, we tested if the replication competent AdLPE1A vector results in a direct cytotoxic effect in hepatocelluar carcinoma (HCC) cells. In vitro cytotoxicity tests were carried out with replication-competent (AdLPE1A) and -incompetent (AdLPCD) LP-driven vectors. AdLPE1A is an AV in which LP was inserted 5' to the E1A and E1B genes. The AdLPCD vector contains LP and the E. coli cytosine deaminase (CD) gene in transcription unit. Exposure of cells to AdLPE1A generated a significant cytotoxic effect as compared to the control. Almost 90% of the cell had manifested the characteristic cytopatic effect on day 9 after infection of cells with 10 MOI of AdLPE1A. On the other hand, almost 35% of the cells were left when the cells had been treated with 100 MOI of AdLPCD together with 5-FC on day 9 when compared with the cells which had never been exposed neither 5-FC nor AdLPCD. These results showed that the replication competent AdLPE1A vector could kill the HepG2 cells directly by the oncolytic effect of the virus. The replication competent AV vector carrying viral E1A generated greater cytotoxic effect than the replication incompetent AV, which contains the CD prodrug activation transcription unit without E1A, in HepG2 cells.

Keywords

References

  1. Akbulut, H., Zhang, L., Tang, Y., and Deisseroth, A., Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon. Cancer Gene Ther., 10(5), 388-395 (2003) https://doi.org/10.1038/sj.cgt.7700579
  2. Akbulut, H., Tang, Y., Maynard, J., Zhang, L., Pizzorno, G., and Deisseroth, A., Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms. Clin. Cancer Res., 10(22), 7738-7746 (2004) https://doi.org/10.1158/1078-0432.CCR-04-0490
  3. Alemany, R., Balague, C., and Curiel, D T. (2000). Replicative adenoviruses for cancer therapy. Nature Biotechnol. 18(7), 723-727 https://doi.org/10.1038/77283
  4. Chung, I., Schwartz, P. E., Crystal, R. G., Pizzorno, G., Leavitt, J. L., and Deisseroth, A. B., Use of L-plastin promoter to develop adenoviral system which confers trans gene expression in ovarian cancer cells but not in normal mesothelial cells. Cancer Gene Ther., 6(2), 99-106 (1999) https://doi.org/10.1038/sj.cgt.7700017
  5. Chung, I., and Deisseroth, A. B., Recombinant adenoviral vector containing tumor-specific L-plastin promoter fused to cytosine deaminase gene as a transcription unit: generation and functional test. Arch. Pharm. Res., 27(6), 633-639 (2004) https://doi.org/10.1007/BF02980163
  6. Chung, I. (2005). Chemosensitization of human ovarian carcinoma cells by a recombinat adenoviral vector containing L-plastin promoter fused to cytosine deaminase transcription unit. J. Applied Pharmacol. 13, 143-149
  7. Graham, F. L., and Prevec, L. (1991). Manipulation of adenovirus vectors, Methods in molecular biology, Vol. 7, pp 109-128. E. J. Murray, The Human Press Inc., Clifton, NJ
  8. Heise, C., Kirn, D. H. (2000). Replication-selective adenoviruses as oncolytic agents. J. Clin. Invest. 105(7), 847-851 https://doi.org/10.1172/JCI9762
  9. Leavitt, J., Discovery and characterization of two novel huarun cancer-related proteins using two-dimensional gel electrophoresis. Electrophoresis, 15, 345-357 (1994) https://doi.org/10.1002/elps.1150150154
  10. Lin, C.-S., Park, T., Chen, Z. P., and Leavitt, J. L., Human plastin genes. J. Biol. Chem., 268(4), 2781-2792 (1993a)
  11. Lin, C.-S., Chen, Z. P., Park, T., Ghosh, K., and Leavitt, J., Characterization of the human L-plastin gene promoter in normal and neoplastic cells. J. Biol. Chem., 268(4), 2793-2801 (1993b)
  12. Miyatake, S. I., Tani, S., Feigenbaum, F., Sundaresan, P., Toda, H., Narumi, O., Kikuchi, H., Hashimoto, N., Hangai, M., Martuza, R. L., Rabkin, S. D. (1999). Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo. Gene Ther. 6(4), 564-572 https://doi.org/10.1038/sj.gt.3300861
  13. Peng, X. Y., Won, J. H., Rutherford, T., Fujii, T., Zelterman, D., Pizzorno, G., Sapi, E., Leavitt, J., Kacinski, B., Crystal, R., Schwartz, P., and Deisseroth, A., The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines. Cancer Res., 61(11), 4405-4413 (2001)
  14. Rodriguez, R., Schuur, E. R., Lim, H. Y., Henderson, G. A., Simons, J. W., Henderson, D. R. (1997). Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res. 57(13), 2559-2563
  15. Zhang, L., Akbulut, H., Tang, Y., Peng, X., Pizzorno, G., Sapi, E., Manegold, S., and Deisseroth, A., Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma. Mol. Ther., 6(3), 386-393 (2002) https://doi.org/10.1006/mthe.2002.0680